MedPage Today on MSN
Sniffing Out the Optimal Radiation Dose for Head and Neck Cancer
Sense of smell in patients with head and neck cancer began to deteriorate at a radiation dose of 22 Gy and increased in a ...
Hosted on MSN
Radiation therapy does not improve survival rates for some women with breast cancer, study finds
While radiation has been a standard treatment for breast cancer patients since the early 20th century, a new study shows that it does not significantly improve survival for women with early-stage ...
New research found patients with certain head and neck cancers lived longer and experienced fewer side effects when treated ...
The James Cancer Hospital's innovative procedure places short-range radiation directly into glioblastoma tumors, addressing ...
ROCHESTER — Certain cases of breast cancer can be treated with less intense doses of radiation therapy over fewer days, a recently published Mayo Clinic study found. "The standard at the time, for ...
Radiation therapy offered no survival benefit for women with early-stage breast cancer who received mastectomy, lymph node surgery and cancer drugs, according to an international study published Nov.
14don MSN
Preoperative radiation may improve antitumor immune response in most common form of breast cancer
Preoperative radiation improved T-cell infiltration (TCI) in patients with hormone receptor (HR)-positive, HER2-negative ...
Perioperative chemotherapy is recommended for patients with cT2-4 and/or N+ resectable gastric cancer, preferably 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT).
Glioblastoma often kills within months. A new targeted radiation therapy may help patients live longer. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...
News-Medical.Net on MSN
Preoperative radiation may enhance treatment response in patients with HR-positive, HER2-negative breast cancer
Preoperative radiation improved T-cell infiltration (TCI) in patients with hormone receptor (HR)-positive, HER2-negative breast cancer when administered in combination with pembrolizumab (Keytruda) ...
News-Medical.Net on MSN
Proton therapy improves survival in oropharyngeal cancer patients
A new study published today in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who ...
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has developed and validated an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results